Jupiter Wellness Acquisition Corp. (Nasdaq: JWAC) (“JWAC”)
announced today that its special meeting of stockholders (the
“Meeting”), which was originally scheduled for April 20, 2023, has
been postponed to
10:00 a.m. Eastern Time, on Tuesday, May
2, 2023. At the Meeting, stockholders of JWAC will be
asked to vote on proposals to approve, among other things, its
initial business combination with Chijet Inc., a Cayman Islands
exempted company (“Chijet”), each of the referenced holders of
Chijet’s outstanding shares (collectively, the “Sellers”), Chijet
Motor Company, Inc., a Cayman Islands exempted company and
wholly-owned subsidiary of Chijet (“Pubco”), and Chijet Motor (USA)
Company, Inc., a Delaware corporation and a wholly-owned subsidiary
of Pubco (“Merger Sub”), which JWAC previously announced on its
Current Report on Form 8-K dated October 31, 2022, as amended (the
“Business Combination”). There is no change to the location, the
record date, the purpose or any of the proposals to be acted upon
at the Meeting.
As a result of this change, the Meeting will now
be held at 10:00 a.m. Eastern Time on Tuesday, May 2,
2023, via the live webcast at
https://web.lumiagm.com/285719486.
Also as a result of this change, JWAC has
extended the deadline for holders of JWAC’s common stock as of the
record date of March 8, 2023 to submit their publicly held shares
for redemption in connection with the Business Combination to 5:00
p.m. Eastern Time on Friday, April 28, 2023. Stockholders who wish
to withdraw their previously submitted redemption requests may do
so prior to the Meeting by requesting the Company’s transfer agent
American Stock Transfer & Trust Company to return such
shares.
If stockholders have any questions or need
assistance please call JWAC’s proxy solicitor, Advantage Proxy,
Inc., 24925 13th Place South, Des Moines, WA 98198; (877) 870-8565
(toll free) or (206) 870-8565 (collect); or by email at
ksmith@advantageproxy.com.
ABOUT JWAC
JWAC is a special purpose acquisition company
formed for the purpose of entering a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization, or
other similar business combination with one or more businesses or
entities. JWAC began trading on the Nasdaq in December 2021, and
its common stock and rights are traded under the ticker symbols
JWAC and JWACR, respectively.
ABOUT
CHIJET
The primary business of Chijet is the
development, manufacture, sales and service of traditional fuel
vehicles and electric vehicles. State-of-the-art manufacturing
systems and stable supply chain management enable the company to
provide consumers with products of high performance at reasonable
prices. The factory in Yantai, China, will be dedicated to EV
production, and the company’s headquarters will be also located at
the planned Yantai factory. Chijet has a management team of
industry veterans with decades of experience in engineering and
design, management, financing, industrial production and financial
management.
ADDITIONAL INFORMATION
Pubco has submitted with the SEC a Registration
Statement on Form F-4 (as amended, the “Registration
Statement”), which was declared effective on March 30,
2023 and included a proxy statement of JWAC and a prospectus of
Pubco in connection with the proposed transactions (the
“Transactions”) involving JWAC, Chijet, the
Sellers and Merger Sub pursuant to that certain Business
Combination Agreement executed in connection with the Business
Combination. The definitive proxy statement and other relevant
documents were being mailed to stockholders of JWAC as of a record
date of March 8, 2023. STOCKHOLDERS OF JWAC AND OTHER INTERESTED
PARTIES ARE URGED TO READ, WHEN AVAILABLE, THE DEFINITIVE PROXY
STATEMENT IN CONNECTION WITH JWAC’s SOLICITATION OF PROXIES FOR THE
SPECIAL MEETING OF ITS STOCKHOLDERS TO BE HELD TO APPROVE THE
TRANSACTIONS BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT
INFORMATION ABOUT JWAC, CHIJET, PUBCO, THE SELLERS AND THE
TRANSACTIONS. Stockholders will also be able to obtain copies of
the Registration Statement and the proxy statement/prospectus,
without charge, once available, on the SEC’s website at www.sec.gov
or by directing a request to JWAC by contacting its Chief Executive
Officer, Brian John, Jupiter Wellness Acquisition Corp., 1061 E.
Indiantown Road, Suite 110, Jupiter, Florida 33477, at (561)
244-7100.
DISCLAIMER
This report hereto shall not constitute an offer
to sell or the solicitation of an offer to buy any securities, nor
shall there be any sale of securities in any jurisdiction in which
the offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
jurisdiction. No offering of securities shall be made except by
means of a prospectus meeting the requirements of Section 10 of the
Securities Act of 1933, as amended, or an exemption therefrom.
NO ASSURANCES
There can be no assurance that the proposed
Transactions will be completed, nor can there be any assurance, if
the Transactions are completed, that the potential benefits of
combining the companies will be realized. The description of the
Transactions contained herein is only a summary and is qualified in
its entirety by reference to the definitive agreements relating to
the Transactions, copies of which have been filed with the SEC as
exhibits to the Registration Statement.
PARTICIPANTS IN THE SOLICITATION
JWAC, Chijet and their respective directors and
executive officers may be deemed to be participants in the
solicitation of proxies from the stockholders of JWAC in connection
with the Transactions. Information regarding the officers and
directors of JWAC is set forth in JWAC’s annual report on Form
10-K, which was filed with the SEC on December 30, 2022. Additional
information regarding the interests of such potential participants
are included in the Registration Statement (and is included in the
definitive proxy statement/prospectus for the Transactions) and
other relevant documents filed with the
SEC.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS
The information in this report contains certain
“forward-looking statements” within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act
of 1995 with respect to the proposed business combination. These
forward-looking statements generally are identified by the words
“believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,”
“strategy,” “future,” “opportunity,” “plan,” “may,” “should,”
“will,” “would,” “will be,” “will continue,” “will likely result”
and similar expressions, but the absence of these words does not
mean that a statement is not forward-looking. Forward-looking
statements are predictions, projections and other statements about
future events that are based on current expectations and
assumptions and, as a result, are subject to risks and
uncertainties. Actual results may differ from their expectations,
estimates and projections and consequently, you should not rely on
these forward-looking statements as predictions of future events.
Many factors could cause actual future events to differ materially
from the forward-looking statements in this press release,
including but not limited to: (i) the risk that the business
combination may not be completed in a timely manner or at all,
which may adversely affect the price of JWAC’s securities; (ii) the
failure to satisfy the conditions to the consummation of the
business combination, including the approval of the business
combination agreement by the stockholders of JWAC; (iii) the
occurrence of any event, change or other circumstance that could
give rise to the termination of the business combination agreement;
(iv) the outcome of any legal proceedings that may be instituted
against any of the parties to the business combination agreement
following the announcement of the entry into the business
combination agreement and proposed business combination; (v) the
ability of the parties to recognize the benefits of the business
combination agreement and the business combination; (vi) the lack
of useful financial information for an accurate estimate of future
capital expenditures and future revenue; (vii) statements regarding
Chijet’s industry and market size; (viii) financial condition and
performance of Chijet and Pubco, including the anticipated
benefits, the implied enterprise value, the expected financial
impacts of the business combination, potential level of redemptions
of JWAC’s public stockholders, the financial condition, liquidity,
results of operations, the products, the expected future
performance and market opportunities of Chijet and Pubco; and (ix)
those factors discussed in JWAC’s and Pubco’s filings with the SEC
and that will be contained in the registration statement on Form
F-4 and the related proxy statement relating to the business
combination. You should carefully consider the foregoing factors
and the other risks and uncertainties that will be described in the
“Risk Factors” section of the registration statement on Form F-4
and related proxy statement and other documents to be filed by JWAC
or Pubco from time to time with the SEC. These filings identify and
address other important risks and uncertainties that could cause
actual events and results to differ materially from those contained
in the forward-looking statements. Forward-looking statements speak
only as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and while Chijet,
JWAC and Pubco may elect to update these forward-looking statements
at some point in the future, they assume no obligation to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise, subject to applicable law.
None of Chijet, JWAC or Pubco gives any assurance that Chijet, JWAC
or Pubco will achieve its expectations.
Contact:
Jupiter Wellness Acquisition Corp.Brian S. JohnChief Executive
Officer1061 E. Indiantown Road, Suite 110Jupiter, FL 33477(561)
244-7100
Jupiter Wellness Acquisi... (NASDAQ:JWAC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Jupiter Wellness Acquisi... (NASDAQ:JWAC)
Historical Stock Chart
From Nov 2023 to Nov 2024